A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.

Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction. Its pathological hallmark is the abnormal aggregation of α-synuclein (α-syn ...

In a new frontier for deep brain stimulation, researchers used A.I. to develop individualized algorithms, which helped a skateboarder and other patients with Parkinson’s disease. By Pam Belluck ...

Deep brain stimulation (DBS) is a treatment for various neurological conditions such as Parkinson’s disease and obsessive-compulsive disorder. It involves surgically implanting an electrode into your ...

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...

Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach to ...

An ultrasound device that can precisely stimulate areas deep in the brain without surgery has been developed by researchers from UCL and the University of Oxford, opening up new possibilities for ...

Please provide your email address to receive an email when new articles are posted on . The potential for deep brain stimulation rests in the ability for accurate location of biomarkers. Personalized ...

An Ohio music conductor is using deep brain stimulation to combat his Parkinson’s disease. Rand Laycock, 70, the director and conductor of a symphony orchestra, was diagnosed just before his 60th ...